Emily Casanova is research assistant professor of biomedical sciences at the University of South Carolina School of Medicine Greenville.
Emily Casanova
Research assistant professor
University of South Carolina
From this contributor
How the autonomic nervous system may govern anxiety in autism
The branch of the nervous system that regulates subconscious bodily processes such as breathing and digestion may play a key role in autism.
How the autonomic nervous system may govern anxiety in autism
What Ehlers-Danlos syndrome can teach us about autism
Not much is known about the connection between autism and Ehlers-Danlos syndrome, a condition that affects collagen. But preliminary work provides tantalizing clues.
What Ehlers-Danlos syndrome can teach us about autism
Evolution of autism genes hints at their fundamental roles in body
Genes associated with autism are ancient, and mutations in them have wide-ranging effects on the body, indicating their importance.
Evolution of autism genes hints at their fundamental roles in body
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.